U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602790) titled 'Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE' on May 04.
Brief Summary: EMBRACE is a randomized, controlled, multicenter clinical study evaluating the effect of renal denervation on clinical adverse events in hypertensive patients undergoing staged percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Multivessel Coronary Artery Disease
Hypertension Resistant to Conventional Therapy
Intervention:
DEVICE: Renal denervation
Catheter-based renal denerva...